tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
URGN is currently covered by 5 analysts with an average price target of $33.18. This is a potential upside of $11.83 (55.41%) from yesterday's end of day stock price of $21.35.
UroGen Pharma Ltd's activity chart (see below) currently has 106 price targets and 97 ratings on display. The stock rating distribution of URGN is 88.46% BUY and 11.54% HOLD.
Analysts average stock forecasts to be materialized ratio is 48.7% with an average time for these price targets to be met of 241 days.
Highest price target for URGN is $40, Lowest price target is $3, average price target is $28.6.
Most recent stock forecast was given by JASON KOLBERT from D. BORAL CAPITAL on 23-Jan-2026. First documented stock forecast 30-May-2017.
Currently out of the existing stock ratings of URGN, 23 are a BUY (88.46%), 3 are a HOLD (11.54%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 14-Oct-2024
$33
$11.65 (54.57%)
$33
15 days ago
(23-Jan-2026)
18/20 (90%)
$13 (65.00%)
237
Buy Since 08-Jul-2025
$40
$18.65 (87.35%)
$40
3 months 11 days ago
(27-Oct-2025)
6/27 (22.22%)
$19.15 (91.85%)
1019
Buy Since 28-Feb-2019
$31
$9.65 (45.20%)
$10
7 months 25 days ago
(13-Jun-2025)
2/18 (11.11%)
$18.97 (157.69%)
42
Hold Since 29-May-2019
$3
$-18.35 (-85.95%)
$16
8 months 16 days ago
(22-May-2025)
5/10 (50%)
$-1.08 (-26.47%)
454
Buy Since 04-Apr-2018
$36
$14.65 (68.62%)
10 months 27 days ago
(11-Mar-2025)
1/2 (50%)
$25.18 (232.72%)
94
What is URGN (UroGen Pharma Ltd) average time for price targets to be met?
Which analyst has the current highest performing score on URGN (UroGen Pharma Ltd) with a proven track record?
Which analyst has the current lower performing score on URGN (UroGen Pharma Ltd) with a proven track record?
Which analyst has the most public recommendations on URGN (UroGen Pharma Ltd)?
Which analyst is the currently most bullish on URGN (UroGen Pharma Ltd)?
Which analyst is the currently most reserved on URGN (UroGen Pharma Ltd)?
